// App-Quantinova.ai

: Exploratory analysis of predictive biomarkers for immune-related adverse events (irAEs) due to checkpoint inhibitors (CPIs) in patients with genitourinary (GU) cancers.

Researchers

Presenter

  • Elham Vosoughi

Principal Investigators

  • Dalia Kaakour

  • Wen-Pin Chen

  • Nataliya Mar

Medical Centers

  • University of California, Irvine, Dana Point, CA

  • University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Renal cell carcinoma

  • Solid malignancies

Biomarkers

  • Programmed death-ligand 1

  • X-Ray Repair Cross Complementing 1

  • Tumor mutational burden

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved